BioAmber (BIOA) Misses Q2 EPS by 4c

BioAmber (NYSE: BIOA) reported Q2 EPS of ($0.26), $0.04 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $3.7 million versus the consensus estimate of $3.85 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• Oracle reports earnings today: AI spending bet faces its toughest test yet
• Monolithic Power Systems (MPWR) Reiterated at Buy by Stifel on Reaching $4B Target
• DA Davidson Reiterates Buy Rating on EVI Industries Inc. (EVI) Following Q4 Results